Preliminary Data From CAR-T Phase I Clinical Trial for NSCLC to be Presented by Cellular Biomedicine at 5th World Congress on Cancer Therapy
Lung Cancer, News
Cellular Biomedicine, a biotechnology company developing cell-based therapies to address degenerative diseases and immunotherapies for cancer, recently announced they will present new clinical findings at the 5th World Congress on Cancer Therapy, taking place on September 28, ... Read more